Immune Checkpoint Inhibitor-Induced Acute Pancreatitis and Colitis

Given the promising response of immune checkpoint inhibitors (ICPIs) in treating advanced malignancies, their use in clinical practice is on the rise. ICPIs are associated with a wide spectrum of immune-related adverse events (irAEs). The reported side effects of therapy can be severe enough to requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagan, Andrea, Arroyo-Martinez, Yadis M, Tandon, Ankita, Bertran-Rodriguez, Carlos, Gill, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294850/
https://www.ncbi.nlm.nih.gov/pubmed/32550093
http://dx.doi.org/10.7759/cureus.8613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294850/
https://www.ncbi.nlm.nih.gov/pubmed/32550093
http://dx.doi.org/10.7759/cureus.8613

Ejemplares similares